SCARB1 and atherosclerosis: We found that ASA increased the expression of SR-BI and ABCA1, so reducing the cholesterol levels in foam cells and potentially slowing down the progression of atherosclerosis, which is in agreement with the observations made by Cyrus T in the low LDL receptor-deficient mice [10].